Momentous - that's how one leading UK dementia charity described the approval of the Alzheimer's drug lecanemab back in August 2024.
Pat Hagan is a Reporter at various esteemed publications including The Mirror, The Sun, and The Daily Mail. He specializes in health and wellness, with a strong focus on cannabis, psychedelics, and alternative medicine, often covering topics such as cannabidiol (CBD), cannabis regulation, and consumer health. Pat's insightful work has been featured in numerous outlets, highlighting his expertise in medicine and healthcare.












